+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Breast Cancer Drugs Market Research Reports

From
From
From
Global Breast Cancer Drug Market & Clinical Trial Insight 2025 - Product Thumbnail Image

Global Breast Cancer Drug Market & Clinical Trial Insight 2025

  • Clinical Trials
  • January 2020
  • 1140 Pages
From
US Breast Cancer Drug Market Outlook 2022 - Product Thumbnail Image

US Breast Cancer Drug Market Outlook 2022

  • Report
  • September 2016
  • 130 Pages
From
US Breast Cancer Drug Pipeline Analysis - Product Thumbnail Image

US Breast Cancer Drug Pipeline Analysis

  • Drug Pipelines
  • October 2013
  • 480 Pages
From
From
CAS 89778-26-7 Toremifene Chemical World Report - Product Thumbnail Image

CAS 89778-26-7 Toremifene Chemical World Report

  • Report
  • March 2020
  • 2040 Pages
CAS 865-21-4 Vinblastine Chemical World Report - Product Thumbnail Image

CAS 865-21-4 Vinblastine Chemical World Report

  • Report
  • March 2020
  • 2016 Pages
CAS 76-43-7 Fluoxymesterone Chemical World Report - Product Thumbnail Image

CAS 76-43-7 Fluoxymesterone Chemical World Report

  • Report
  • March 2020
  • 2179 Pages
CAS 59-05-2 Methotrexate Chemical World Report - Product Thumbnail Image

CAS 59-05-2 Methotrexate Chemical World Report

  • Report
  • March 2020
  • 2111 Pages
CAS 95058-81-4 Gemcitabine Chemical World Report - Product Thumbnail Image

CAS 95058-81-4 Gemcitabine Chemical World Report

  • Report
  • March 2020
  • 2134 Pages
CAS 51-21-8 5-Fluorouracil Chemical World Report - Product Thumbnail Image

CAS 51-21-8 5-Fluorouracil Chemical World Report

  • Report
  • March 2020
  • 2054 Pages
CAS 50-18-0 Cyclophosphamide Chemical World Report - Product Thumbnail Image

CAS 50-18-0 Cyclophosphamide Chemical World Report

  • Report
  • March 2020
  • 2011 Pages
Loading Indicator

Over a million women worldwide are diagnosed with breast cancer annually. Alongside surgery, radiotherapy and immunotherapy, pharmaceutical products (including hormonal therapy and chemotherapy) are in the frontline against this terrible disease. Market reports in this section enable buyers to read up on the latest breast cancer drug pipelines and R&D strategies, as well as the medical and commercial activities of major players and niche operators such Abraxis Bioscience, Aeterna Zentaris, Agendia BV, Aphton Corp, Array BioPharma, AstraZeneca Plc, Bristol Myers Squibb, Dendreon Corporation, Eli Lilly, Genentech, Genta, Novartis AG, Pfizer, Roche Group, Sanofi-Aventis, Schering AG, Therion Biologics, and ViRexx Medical. Also included are cutting edge academic journals and various expert textbooks for medical professionals involved in breast cancer treatment. Show Less Read more

adroll